Home/Filings/4/0001209191-17-049317
4//SEC Filing

Meyers Pete A. 4

Accession 0001209191-17-049317

CIK 0000827871other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 8:30 PM ET

Size

5.3 KB

Accession

0001209191-17-049317

Insider Transaction Report

Form 4
Period: 2017-08-16
Meyers Peter A.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2017-08-16$55.45/sh+350$19,406700 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.4294 to $55.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1
  • filerCIK 0001590862

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:30 PM ET
Size
5.3 KB